Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool
LONDON, April 30, 2026 /PRNewswire/ -- Serac Healthcare Limited ('Serac Healthcare' or 'the Company'), a clinical radiopharmaceutical company developing an innovative molecular imaging agent, 99mTc-maraciclatide, and the Nuffield Department of Women's & Reproductive Health at the...
View original →